Zobrazeno 1 - 10
of 216
pro vyhledávání: '"Qi-Long, Yi"'
Autor:
Yi-Chan J. Lin, David H. Evans, Ninette F. Robbins, Guillermo Orjuela, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 4 (2023)
ABSTRACT The 50% plaque reduction neutralization assay (PRNT50) has been previously used to assess the neutralization capacity of donor plasma against wild-type and variant of concern (VOC) severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
Externí odkaz:
https://doaj.org/article/f93dfd1b347d4c63b1a281495f79c86e
Autor:
Sheila F. O’Brien, Niamh Caffrey, Qi-Long Yi, Shelly Bolotin, Naveed Z. Janjua, Mawuena Binka, Caroline Quach Thanh, Derek R. Stein, Amanda Lang, Amy Colquhoun, Chantale Pambrun, Cassandra N. Reedman, Steven J. Drews
Publikováno v:
Microbiology Spectrum, Vol 11, Iss 1 (2023)
ABSTRACT We compared the seroprevalence of SARS-CoV-2 anti-nucleocapsid antibodies in blood donors across Canadian regions in 2021. The seroprevalence was the highest in Alberta and the Prairies, and it was so low in Atlantic Canada that few correlat
Externí odkaz:
https://doaj.org/article/0567c8147d8c44efabc66862e8a91bfe
Autor:
Yi-Chan J. Lin, David H. Evans, Ninette F. Robbins, Guillermo Orjuela, Queenie Hu, Reuben Samson, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 5 (2022)
ABSTRACT There is evidence that COVID-19 convalescent plasma may improve outcomes of patients with impaired immune systems; however, more clinical trials are required. Although we have previously used a 50% plaque reduction/neutralization titer (PRNT
Externí odkaz:
https://doaj.org/article/a39f915935f94354b6ed5345697456bb
Autor:
Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Ninette F. Robbins, Guillermo Orjuela, Craig Jenkins, Valerie Conrod, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 3 (2022)
ABSTRACT Our group has previously used laboratory and commercially developed assays to understand the IgG responses to SARS-CoV-2 antigens, including nucleocapsid (N), spike (S), and receptor binding domain (RBD), in Canadian blood donors. In this cu
Externí odkaz:
https://doaj.org/article/ef5564a89fd54ae8954f40d0ea33902f
Autor:
Sheila F. O’Brien, Cassandra N. Reedman, Carla Osiowy, Shelly Bolotin, Qi-Long Yi, Lillian Lourenço, Antoine Lewin, Mawuena Binka, Niamh Caffrey, Steven J. Drews
Publikováno v:
Viruses, Vol 15, Iss 2, p 409 (2023)
Hepatitis B surveillance is essential to achieving Canada’s goal of eliminating hepatitis B by 2030. Hepatitis B rates, association of infection with vaccine age-eligibility, and risk factors were analyzed among 1,401,603 first-time Canadian blood
Externí odkaz:
https://doaj.org/article/b5b2447f2c1a4584ba0d9d6119315764
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 2 (2022)
ABSTRACT We monitored the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nucleocapsid (anti-N; proxy of natural infection) and spike protein (anti-S; proxy for humoral immunity) antibodies in blood donors across Canada
Externí odkaz:
https://doaj.org/article/82fd753de84b44e4a4b0fde4a56aec32
Autor:
Steven J. Drews, Queenie Hu, Reuben Samson, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Qi-Long Yi, Sheila F. O’Brien
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 1 (2022)
ABSTRACT This study attempted to understand the levels of neutralizing titers and the breadth of antibody protection against wild-type and variant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Canadian blood donors during the first
Externí odkaz:
https://doaj.org/article/885f664339044a1db4c1365fbed4d19a
Autor:
Ashleigh R. Tuite, David Fisman, Kento T. Abe, Bhavisha Rathod, Adrian Pasculescu, Karen Colwill, Anne-Claude Gingras, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews
Publikováno v:
Microbiology Spectrum, Vol 10, Iss 1 (2022)
ABSTRACT We have previously used composite reference standards and latent class analysis (LCA) to evaluate the performance of laboratory assays in the presence of tarnished gold standards. Here, we apply these techniques to repeated, cross-sectional
Externí odkaz:
https://doaj.org/article/ae916b3aa31b4712b528e632f683986b
Publikováno v:
Viruses, Vol 14, Iss 11, p 2336 (2022)
With the emergence of the SARS-CoV-2 Omicron variant in late 2021, Canadian public health case/contact testing was scaled back due to high infection rates with milder symptoms in a highly vaccinated population. We monitored the seroprevalence of SARS
Externí odkaz:
https://doaj.org/article/3189d65c1770401384b490b0ae7b1ccd
Autor:
Sahar Saeed, Sheila F O'Brien, Kento Abe, Qi-Long Yi, Bhavisha Rathod, Jenny Wang, Mahya Fazel-Zarandi, Ashleigh Tuite, David Fisman, Heidi Wood, Karen Colwill, Anne-Claude Gingras, Steven J Drews
Publikováno v:
PLoS ONE, Vol 16, Iss 9, p e0257743 (2021)
BackgroundSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies bridge the gap left from case detection, to estimate the true burden of the COVID-19 pandemic. While multiple anti-SARS-CoV-2 immunoassays are available, no
Externí odkaz:
https://doaj.org/article/c9912a736b2e46b59cb3a77ede71a5ed